CXCL13 ELISA detects early neuroborreliosis
A new ELISA provides detection of the cytokine CXCL13 in cerebrospinal fluid (CSF) and is the first such assay worldwide to be approved for in vitro diagnostics. CXCL13 represents a novel biomarker for the early diagnosis of acute Lyme neuroborreliosis. It is present at high concentrations in CSF soon after the illness starts, even before […]
